# HIV IMPAACT RELATED STUDIES

> **NIH NIH N01** · WESTAT, INC. · 2020 · $1,746,450

## Abstract

The Eunice Kennedy Shriver National Institute of Child Health and Human Development
(NICHD) seeks to support clinical activities for international and domestic pediatric and maternal HIV
and other high priority infectious diseases. NICHD provides clinical trial sites to some other clinical trial networks such as the
International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) The
IMPAACT network and its leadership group are in charge of the creation of all their studies,
protocols, and clinical trials. These activities are funded through Grants/Cooperative agreements
sponsored by the National Institute of Allergy and Infectious Diseases (NIAID). The
IMPAACT Network is a cooperative group of institutions, investigators, and other
collaborators mainly focused on evaluating potential therapies for HIV infection and its
related symptoms and co-infections in infants, children, adolescents and pregnant women for maternal health.
This includes clinical trials of HIV/AIDS interventions for the prevention of mother to child
transmission.
In 1990 the NICHD began collaborating with the Pediatric AIDS Clinical Trials Group,
(PACTG) to expand clinical trial availability at NICHD clinical trial centers/sites. This
collaboration made possible to conduct clinical trials by the IMPAACT Network to further
evaluate antiretroviral therapeutic agents, other therapies targeted at opportunistic infections,
and interventions to prevent perinatal HIV transmission. In recent years, the collaboration is
expanding to evaluate potential HIV cure approaches and vaccines. The NICHD will
continue providing this Coordinating Center Contract support to the IMPAACT Network
providing access to sites and the clinical populations of interest.

Scope
To perform clinical trials according to the IMPAACT Related protocols maintaining a multi-site network
of domestic and international clinical centers to conduct the research on treatment, prevention, diagnosis,
epidemiology of HIV infection and disease and its infectious and non-infectious complications in
pediatric, adolescent, and maternal patient populations.

## Key facts

- **NIH application ID:** 10165403
- **Project number:** 275201800001I-P00002-27500003-1
- **Recipient organization:** WESTAT, INC.
- **Principal Investigator:** BARBARA DRIVER
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $1,746,450
- **Award type:** —
- **Project period:** 2017-12-01 → 2020-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10165403

## Citation

> US National Institutes of Health, RePORTER application 10165403, HIV IMPAACT RELATED STUDIES (275201800001I-P00002-27500003-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10165403. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*